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Abstract
Background: To determine the clinimetric properties of two questionnaires assessing symptoms
(Symptom Severity Scale) and physical functioning (hand and finger function subscale of the AIMS2)
in a Dutch primary care population.
Methods: The first 84 participants in a 1-year follow-up study on the diagnosis and prognosis of
hand and wrist problems completed the Symptom Severity Scale and the hand and finger function
subscale of the Dutch-AIMS2 twice within 1 to 2 weeks. The data were used to assess test-retest
reliability (ICC) and smallest detectable change (SDC, based on the standard error of measurement
(SEM)). To assess responsiveness, changes in scores between baseline and the 3 month follow-up
were related to an external criterion to estimate the minimal important change (MIC). We
calculated the group size needed to detect the MIC beyond measurement error.
Results: The ICC for the Symptom Severity Scale was 0.68 (95% CI: 0.54–0.78). The SDC was 1.00
at individual level and 0.11 at group level, both on a 5-point scale. The MIC was 0.23, exceeding the
SDC at group level. The group size required to detect a MIC beyond measurement error was 19
for the Symptom Severity Scale. The ICC for the hand and finger function subscale of the Dutch-
AIMS2 was 0.62 (95% CI: 0.47–0.74). The SDC was 3.80 at individual level and 0.42 at group level,
both on an 11-point scale. The MIC was 0.31, which was less than the SDC at group level. The
group size required to detect a MIC beyond measurement error was 150.
Conclusion: In our heterogeneous primary care population the Symptom Severity Scale was
found to be a suitable instrument to assess the severity of symptoms, whereas the hand and finger
function subscale of the Dutch-AIMS2 was less suitable for the measurement of physical functioning
in patients with hand and wrist problems.
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Background
Health status questionnaires have become increasingly
popular as measurement instruments in epidemiological
studies. However, the scores on these instruments can be
difficult to interpret. Therefore, there is a need to define
which scores or changes in scores on these questionnaires
are important. We designed a 1-year follow-up study on
the diagnosis and prognosis of hand and wrist complaints
in primary care, in which self-administered question-
naires were used to study the impact and prognosis of
hand and wrist problems. We determined the clinimetric
properties of two questionnaires in a Dutch primary care
population of patients with hand and wrist problems: 1)
the Dutch version of the Symptom Severity Scale, assess-
ing symptoms [1] and 2) the hand and finger function
subscale of the Arthritis Impact Measurement Scales
(Dutch-AIMS2-HFF), assessing physical functioning [2,3].
The two questionnaires have been found to be valid and
reliable in their respective target populations: 1) people
suffering from carpal tunnel syndrome and 2) people suf-
fering from rheumatoid arthritis (RA). Our aim was to
determine whether these questionnaires are also applica-
ble in a less specific group of patients who consult their
general practitioner (GP) for hand and wrist problems.
We assessed the reproducibility and responsiveness of
these questionnaires, and also estimated the minimal
important change.
Methods
Questionnaires
The Symptom Severity Scale is a self-administered ques-
tionnaire that has been developed to assess the severity of
symptoms in patients with carpal tunnel syndrome. This
questionnaire contains eleven questions with multiple-
choice responses, with a score ranging from 1 point (mild-
est) to 5 points (most severe) (Table 1). The total symp-
tom severity score is calculated as the mean of the scores
for the eleven individual items [1]. In a clinical study, Lev-
ine et al. demonstrated that the instrument had good
reproducibility, consistency, validity and responsiveness
in patients with carpal tunnel syndrome [1].
The Arthritis Impact Measurement Scales (AIMS) were
designed specifically to assess health status in patients
with rheumatic diseases [4]. The AIMS2 is a revised and
extended version of the AIMS, and has been translated
into Dutch to assess RA patients in the Netherlands [5].
The Dutch-AIMS2 is a self-administered questionnaire
which measures 3 different domains of health status:
physical, psychological and social aspects. In the present
study we only used questions pertaining to the physical
domain, namely questions about hand and finger func-
tion. The patients were asked to indicate, on a 5-point Lik-
ert scale, how often during the previous 4 weeks they had
been limited in hand and finger function while perform-
ing 5 specific tasks: writing with a pen or pencil; buttoning
up a shirt; turning a key; tying knots or shoelaces; opening
a jar. The scores, ranging from 1 (every day) to 5 (never)
for each of the items, were transformed to a total score,
ranging from 0 (representing good health status) to 10
points (representing poor health status). The Dutch
AIMS2 has been found to have good measurement prop-
erties [2,3,5].
Study design and population
The study population consisted of participants in a 1-year
follow-up study on the diagnosis and prognosis of hand
and wrist problems. Patients were eligible for participa-
tion in the study if they were 18 years of age or older, and
capable of filling in questionnaires in the Dutch language.
Patients were excluded from the study if their symptoms
were caused by acute trauma, injury, fracture, vascular
problems or skin problems. The study was approved by
the Medical Ethics Committee of the VU University Med-
ical Centre in Amsterdam.
The first 84 participants who returned the baseline ques-
tionnaire received the Symptom Severity Scale and the
Dutch-AIMS2-HFF a second time within 1 to 2 weeks after
the date on which they completed the first questionnaire.
These data were used to assess reproducibility. To assess
test-retest reproducibility the time-interval needs to be
sufficiently short to support the assumption that the con-
dition remains stable, and sufficiently long to prevent
recall [6]. The baseline and 3-month follow-up data were
used to assess responsiveness.
Data-analysis: reproducibility
Reproducibility concerns the degree to which repeated
measurements in stable persons provide similar results. In
other words, reproducibility is the extent to which an
instrument is free of measurement error. This was assessed
by rating test-retest reliability and agreement [7].
Test-retest reliability
As a parameter of reliability, we computed the intraclass
correlation coefficient (ICCagreement) for the Symptom
Severity Scale and the Dutch-AIMS2-HFF by using a two-
way random effects model [8]. An ICC > .70 is generally
considered to indicate good reliability [9].
Agreement
The Bland and Altman method was used to quantify
agreement, by calculating the mean difference (Mean Δ)
between the two measurements and the standard devia-
tion (SD) of this difference [10]. The closer the Mean Δ is
to zero and the smaller the SD of this difference, the better
the agreement. The 95% limits of agreement were defined
as the mean difference between the measurements ±
1.96*SD of the differences. We also computed the stand-Health and Quality of Life Outcomes 2006, 4:87 http://www.hqlo.com/content/4/1/87
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ard error of measurement (SEM) for both scales. The
smaller the measurement error, the smaller the changes
that can be detected beyond measurement error. The SEM
was estimated by calculating the square root of the within
subject variance of the patients (SEM = √σbetween measurement
+ σresidual) [7].
Smallest detectable change
The smallest detectable change (SDC) was based on this
absolute measurement error. To be 95% confident that
the observed change is real change, and not caused by
measurement error, the smallest detectable change at indi-
vidual level (SDCind) was calculated as 1.96*√2*SEM. The
smallest detectable change at group level (SDCgroup) was
calculated as (1.96*√2*SEM)/√n [11,12].
Data-analysis: responsiveness
Responsiveness refers to an instrument's ability to detect
important change over time in the concept being meas-
ured [13,14]. Responsiveness can be tested by relating the
smallest detectable change (SDC) to the minimal impor-
tant change (MIC). The absolute measurement error
should be smaller than the minimal amount of change in
the scale that is considered to be important [15]. We used
an anchor-based approach to determine the minimally
important change for the Dutch-AIMS2-HFF and the
Symptom Severity Scale. At each follow-up measurement,
the patients were asked to score the change in their ability
to perform daily activities. The seven response options
were: (1) 'very much improved'; (2) 'much improved'; (3)
'little improved'; (4) 'no change'; (5) 'little deterioration';
(6) 'much deterioration'; (7) 'very much deterioration'.
This measure of change was used as the anchor (external
criterion) for the evaluation of responsiveness.
The minimal important change (MIC) was quantified by
constructing receiver operating characteristic (ROC)
curves [16]. The ROC curve is the result of using different
cut-off points for change scores, each with a given sensitiv-
ity and specificity. To determine the MIC we defined the
optimal cut-off point as the point closest to the upper left
corner of the ROC curve, which is assumed to represent
the lowest overall misclassification. This MIC was related
to the SDC by computing the group size needed to achieve
an SDCgroup that equals the MIC (n = (SDC/MIC)2) [11].
We also computed the area under the curve (AUC), which
can be interpreted as the probability of correctly identify-
ing an improved patient from randomly selected pairs of
improved and stable patients [17,18]. An AUC of 1.0 indi-
cates perfect discrimination between these two health
states. An instrument that does not discriminate any bet-
ter than chance will have an AUC of 0.50 [18].
Finally, we assessed the presence of floor and ceiling
effects, by examining the frequency of the highest and
lowest possible scores at baseline. Floor effects were con-
sidered to be present if more than 15% of the patients had
a minimal score at baseline (1 on the Symptom Severity
Scale or 0 on the Dutch-AIMS2-HFF); ceiling effects were
considered to be present if 15% of the patients had a max-
imum baseline score (5 on the Symptom Severity Scale or
10 on the Dutch-AIMS2-HFF) [19]. The responsiveness of
questionnaires is limited by the presence of floor or ceil-
ing effects, because changes can not be measured in such
cases.
All statistical analyses were performed in SPSS for Win-
dows, Version 12.0.1.
Results
The questionnaire was completed by 84 participants at
baseline. Their mean age was 52.0 years (SD 15.6), and
74% were female. All 84 participants completed the retest
Symptom Severity Scale (on average 10 days later), but 3
participants had more than 20% missing answers on the
Dutch-AIMS2-HFF. These 3 cases were not included in the
analysis of the Dutch-AIMS2-HFF. Table 2 presents the
characteristics of the study population at baseline, includ-
ing age, gender, paid job, diagnosis according to the GP,
and the duration of symptoms on presentation. The three
most frequent diagnoses were osteoarthritis (23.1%),
Repetitive Strain Injury (RSI) (20.5%) and non-specific
symptoms/unclear (20.5%). More than one quarter of the
patients had suffered from their symptoms for longer than
six months.
Results concerning the Symptom Severity Scale
Reproducibility
The mean score at baseline, and at retest (on average 10
days later), and the mean change score are presented in
Table 3. This table shows that over this period a small
mean improvement was found on the Symptom Severity
Scale (1–5).
Results concerning the test-retest reproducibility of the
Symptom Severity Scale are also presented in Table 3. The
ICCagreement was 0.68 (95% CI: 0.54–0.78), which indi-
cates moderate reliability and the SDC at individual level
was 20% (1.00 on a 5-point scale).
Responsiveness
To evaluate responsiveness we used perceived improve-
ment in ability to perform daily activities as external crite-
rion. The Symptom Severity Scale correlated moderately
with this anchor (Spearman's rho 0.69). Table 4 shows the
changes between baseline and 3-month follow-up scores
for the 77 participants who completed the Symptom
Severity Scale after three months. Very few patientsHealth and Quality of Life Outcomes 2006, 4:87 http://www.hqlo.com/content/4/1/87
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reported a deterioration in daily functioning, and we
therefore clustered the scores of patients reporting little,
much or very much deterioration. The mean change
scores increased with greater self-reported improvements
in daily functioning.
Figure 1 presents the ROC curves generated for changes on
the Symptom Severity Scale. Based on the distribution of
scores presented in Table 3, we compared patients report-
ing any improvement on the external criterion (n = 34)
with those reporting no change (stability, n = 34). True
positive rates (sensitivity) and false positive rates (1-spe-
cificity) for the discrimination between improvement and
stability were plotted for multiple cut-off points. The AUC
for the Symptom Severity Scale was 0.90 (95% CI: 0.83–
0.97). A cut-off point of 0.23 approximates the optimal
cut-off point (MIC) between sensitivity (85%) and specif-
icity (86%).
Table 1: The Symptom Severity Scale 
1. How severe is the hand or wrist pain that you have at 
night?
6. Do you have numbness (loss of sensation) in your hand?
1 I do not have hand or wrist pain at night 1 No
2 Mild pain 2 I have mild numbness
3 Moderate pain 3 I have moderate numbness
4 Severe pain 4 I have severe numbness
5 Very severe pain 5 I have very severe numbness
2. How often did hand or wrist pain wake you up during a 
typical night in the past two weeks?
7. Do you have weakness in your hand or wrist?
1 Never 1 No weakness
2 Once 2 Mild weakness
3 Two or three times 3 Moderate weakness
4 Four or five times 4 Severe weakness
5 More than five times 5 Very severe weakness
3. Do you typically have pain in your hand or wrist during 
the daytime?
8. Do you have tingling sensations in your hand?
1 I never have pain during the day 1 No tingling
2 I have mild pain during the day 2 Mild tingling
3 I have moderate pain during the day 3 Moderate tingling
4 I have severe pain during the day 4 Severe tingling
5 I have very severe pain during the day 5 Very severe tingling
4. How often do you have hand or wrist pain during the 
daytime?
9. How severe is numbness (loss of sensation) or tingling at night?
1 Never 1 I have no numbness or tingling at night
2 Once or twice a day 2 Mild
3 Three to five times a day 3 Moderate
4 More than five times a day 4 Severe
5 The pain is constant 5 Very severe
5. How long, on average, does an episode of pain last 
during the daytime?
10. How often did hand numbness or tingling wake you up during a typical night 
during the past two weeks?
1 I never get pain during the day 1 Never
2 Less than 10 minutes 2 Once
3 10 to 60 minutes 3 Two or three times
4 Greater than 60 minutes 4 Four or five times
5 The pain is constant throughout the day 5 More than five times
11. Do you have difficulty with the grasping and use of small objects such as keys or 
pens?
1 No difficulty
2 Mild difficulty
3 Moderate difficulty
4 Severe difficulty
5 Very severe difficultyHealth and Quality of Life Outcomes 2006, 4:87 http://www.hqlo.com/content/4/1/87
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We determined responsiveness by relating the SDC to the
MIC. For the Symptom Severity Scale, the SDCgroup (0.11)
was smaller than the MIC (0.23). The group size required
to detect a MIC beyond measurement error was 19.
Results concerning the Dutch-AIMS2-HFF
Reproducibility
Table 3 shows a small mean deterioration on the Dutch-
AIMS2-HFF (0–10) between the baseline score and the
retest scores. Test-retest reproducibility showed moderate
reliability (ICCagreement: 0.62;95% CI: 0.47–0.74). The
SDCind was 3.80 on an 11-point scale (35%).
Responsiveness
The Dutch-AIMS2-HFF also correlated moderately with
our anchor (Spearman's rho 0.52). Table 4 shows the
mean changes for categories of improvement in daily
activities in patients who completed the questionnaire
after three months (n = 76). Although self-reported
improvement was associated with an improvement on the
scale, there was no gradual increase in scores over catego-
ries of improvement.
Figure 2 presents the ROC curves generated for changes on
the Dutch-AIMS2-HFF. Again, we compared patients
reporting any improvement on the external criterion (n =
33) to those reporting no change (stability, n = 34). The
AUC was 0.79 (95% CI: 0.69–0.90); the optimal cut-off
point (MIC) approximated 0.31 (sensitivity = 70%; specif-
icity = 76%). The SDCgroup was not smaller than the MIC
for the Dutch-AIMS2-HFF (SDCgroup  of 0.42; MIC of
0.31). The group size required to detect a MIC beyond
measurement error was 150. We found a floor effect for
the Dutch-AIMS2-HFF; 30% of the patients had a mini-
mum score of 0 at baseline.
Discussion
In this study we investigated the clinimetric properties of
two questionnaires, the Symptom Severity Scale and the
Dutch version of the hand and finger function subscale of
the Arthritis Impact Measurement Scales (Dutch-AIMS2-
HFF). In our population of primary care patients with
hand or wrist problems, the Symptom Severity Scale had
good reproducibility and responsiveness; the Dutch-
AIMS2-HFF performed less well. The measurement error
(SEM) for the Symptom Severity Scale was smaller (0.36
on a 1–5 scale) than the measurement error for the Dutch-
AIMS2-HFF (1.37 on a 0–10 scale). The Symptom Severity
Scale detected smaller changes than the Dutch-AIMS2-
HFF (20% versus 35%). The responsiveness of the Symp-
tom Severity Scale was also better, with an AUC of 0.90,
compared to 0.79 for the Dutch-AIMS2-HFF, which
means that the Symptom Severity Scale discriminated bet-
ter between improved and stable patients. It should be
noted that we did not aim to compare the properties of
the two questionnaires. Each questionnaire measures its
own concept: the Symptom Severity Scale measures the
severity of symptoms and the Dutch-AIMS2-HFF meas-
ures physical aspects of health status. Our aim was to
examine if these questionnaires could also be applied in a
group of patients for whom the questionnaires were not
designed.
Measurement properties of the Symptom Severity Scale
Levine et al.[1] tested the measurement properties of the
Symptom Severity Scale in a clinical study of patients with
Table 2: Characteristics of patients who returned the questionnaires at baseline and at 1-week follow-up
Characteristics
Age in years: mean (SD) (N = 84) 52.0 (15.6)
Gender (% female) (N = 84) 74%
Paid job (N = 84) 52.4%
Diagnosis according to the GP*(N = 78)
Rheumatoid arthritis 5.1%
Osteoarthritis 23.1%
Tenosynovitis 16.7%
Entrapment, including carpal tunnel syndrome 15.4%
Ganglion 11.5%
Repetitive Strain Injury 20.5%
Non-specific symptoms/unclear 20.5%
Other 10.3%
Duration of symptoms at baseline (N = 84)
< 2 weeks 15.5%
3 – 4 weeks 19.0%
1 – 2 months 17.9%
3 – 6 months 21.4%
> 6 months 26.2%
* more than one answer possible; 30 patients were given >1 diagnosisHealth and Quality of Life Outcomes 2006, 4:87 http://www.hqlo.com/content/4/1/87
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carpal tunnel syndrome. They demonstrated that the
Symptom Severity Scale is highly reproducible (Pearson's
correlation coefficient, r = 0.91), internally consistent
(Cronbach's alpha, 0.89), valid, and responsive to clinical
change (expressed as the effect size: 1.4 for severity of
symptoms).
In our more heterogeneous population, the measurement
properties of the Symptom Severity Scale were found to be
satisfactory.
Measurement properties of the Dutch-AIMS2
Meenan et al. [2] tested the measurement properties of the
AIMS2 in subjects with rheumatoid arthritis (RA) and
subjects with osteoarthritis (OA). Internal consistency
coefficients were 0.72–0.91 in the RA group and 0.74–
0.96 in the OA group. Test-retest reliability was 0.78–0.94.
Validity analyses in both the RA and the OA group
showed that patient designation of an area as a problem
or as a priority for improvement was significantly associ-
ated with a poorer AIMS2 score in that area. Meenan et al.
concluded that the AIMS2 is a questionnaire with excel-
lent measurement properties that should be useful in
arthritis clinical trials and in outcome research. Riemsma
et al. [3] and Evers et al. [5] assessed the reliability and
validity of the Dutch version of the AIMS2 (Dutch-
AIMS2). The internal consistency coefficients for the
health status scales ranged from 0.66 to 0.89 [3] and from
0.65 to 0.91 [5]. Test-retest reliability with a time-interval
of 1 month was high (between 0.73–0.92) [5]. The con-
struct validity of the Dutch-AIMS2 was confirmed by the
results of factor analysis, which identified the three differ-
ent domains [3,5].
In our study the MIC for the Dutch-AIMS2-HFF was small
(0.31), but the measurement error was so large that the
MIC could not be discriminated from measurement error.
The Dutch-AIMS2-HFF was developed for the assessment
of patients with RA [2,3], whereas the patients in our
study suffered from a variety of hand and wrist problems.
It is possible that the Dutch-AIMS2-HFF is not suitable for
this more heterogeneous primary care population. The
presence of a floor effect seems to confirm this suggestion;
because many patients (30%) reported no limitation in
hand and finger function (score 0) at baseline, it was not
possible to detect any improvement in these patients.
Another possible explanation for the poorer performance
of the Dutch-AIMS2-HFF may be the number and nature
of its items. It contains only five questions, all of which
Table 3: Test-retest reproducibility results for the Symptom Severity Scale and the Dutch-AIMS2-HFF
N Mean baseline (SD) Mean 10 days (SD) Δ Mean (SD) Limits of agreement ICCagreement (95% CI) SEM SDCind SDCgroup
Symptom Severity Scale* (1–5) 84 2.09 (0.57) 1.98 (0.69) 0.11 (0.50) -0.87 to 1.09 0.68 (0.54 to 0.78) 0.36 1.00 0.11
Dutch-AIMS2-HFF* (0–10) 81 1.85 (2.09) 2.21 (2.37) -0.32 (1.93) -4.10 to 3.46 0.62 (0.47 to 0.74) 1.37 3.80 0.42
* higher score means worse functioning; SD = standard deviation; ICCagreement = intra-class correlation coefficient for agreement; CI = confidence 
interval; SEM = standard error of measurement; SDCind = smallest detectable change at individual level; SDCgroup = smallest detectable change at 
group level.
Table 4: Changes in scores between baseline and 3-month follow-up for ability to perform daily activities
Symptom Severity Scale
Daily functioning N Δ ± sd median Percentiles
25th 75th
Very much improved 17 0.93 ± 0.63 1.00 0.41 1.41
Much improved 11 0.56 ± 0.39 0.45 0.27 1.00
Little improved 6 0.59 ± 0.34 0.64 0.30 0.86
No change 34 -0.03 ± 0.42 0.00 -0.14 0.18
Deterioration 9 -0.24 ± 0.38 -0.18 -0.45 0.05
Dutch-AIMS2-HFF
N Δ ± sd median Percentiles
25th 75th
Very much improved 16 1.47 ± 1.44 1.00 0.13 3.00
Much improved 11 2.18 ± 2.80 1.00 0.00 4.00
Little improved 6 1.10 ± 1.41 1.06 -0.13 2.25
No change 34 -0.18 ± 1.36 0.00 -0.50 0.50
Deterioration 9 -0.89 ± 2.33 0.00 -1.25 0.00Health and Quality of Life Outcomes 2006, 4:87 http://www.hqlo.com/content/4/1/87
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concern almost equally difficult functions. This may affect
the ability of the instrument to measure within-subject
change.
Methodological considerations
The baseline results showed that almost 50% of the
patients had suffered from their symptoms for more than
three months, and could therefore be defined as chronic.
It is plausible to assume that test-retest reliability would
be higher in patients with chronic symptoms than in
patients with acute or sub-acute symptoms. We performed
a sub-group analysis, in which we compared the ICCagree-
ment between patients with chronic symptoms to that of
patients with more acute symptoms. The results showed
very small differences, indicating that the duration of
symptoms did not affect test-retest reliability.
In our study we used the scores for perceived change in
ability to perform daily activities as external criterion
(anchor) for assessing responsiveness. We could, how-
ever, have opted for pain improvement, or scores for over-
all improvement, but these other options did not correlate
any better with the two questionnaires than the external
criterion that we used. A correlation of more than 0.5 is
considered to be appropriate when selecting an external
criterion for assessing responsiveness [20].
We used an anchor-based approach to determine the MIC.
However, there are also several other methods that can be
used to determine MIC; for example, Jaescke et al. [21],
Norman [22] and Wyrwich [23] used other methods.
Jaescke et al. used the mean change score in people report-
ing a small improvement to determe the MIC. With this
method, the MIC for the Symptom Severity Scale would
be 0.59 (the mean change among patients reporting little
improvement), and for the Dutch-AIMS2-HFF it would be
1.10. Norman et al. found that under many circumstances
the estimates of MIC fall very close to half a SDbaseline.
With this method, the MIC for the Symptom Severity
Scale would be 0.29 and for the Dutch-AIMS2-HFF it
would be 1.05. Wyrwich proposed one SEM as a measure
for MIC [24]. Following this method, the MIC for the
Symptom Severity Scale would be 0.36 and for the Dutch-
AIMS2-HFF it would be 1.37. The anchor-based approach
we used estimates the change score at which the question-
naires discriminate best between improved and stable
patients. This method results in smaller MIC estimates,
compared to the other methods, but may be closer to the
minimal important change. The definition of an optimal
cut-off point (MIC) may depend on the objective for
which the questionnaire is used. For example, if users
(researchers or clinicians) want to be certain that only
improved patients are identified by the questionnaire, a
Receiver operator characteristic (ROC) curve for changes on the Symptom Severity Scale Figure 1
Receiver operator characteristic (ROC) curve for changes on the Symptom Severity Scale.
ROC Curve Symptom Severity Scale
0,0 0,2 0,4 0,6 0,8 1,0
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higher cut-off score can be defined for the MIC, but this
approach will fail to identify more patients with smaller,
yet important changes. We prefer to use the ROC curves
for defining MIC, because this method clearly illustrates
the consequences of selecting different MICs.
Conclusion
In conclusion, the properties of a questionnaire always
depend on the characteristics of the population in which
the questionnaire is used. In our heterogeneous, primary
care population, the Symptom Severity Scale seems to be
a suitable instrument to assess the severity of symptoms,
whereas the hand and finger function subscale of the
Dutch-AIMS2 seems to be less suitable for the measure-
ment of physical functioning in patients with hand and
wrist problems.
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